Topic
Overdose prevention after prison release, regulated supply, and why the status quo is failing at scale under prohibition.
More than 100,000 Americans die of drug overdoses each year — under prohibition, not because of reform. Overdose prevention is not a single intervention. It is regulated supply, fentanyl testing, naloxone access, and reentry protocols that treat the first 72 hours after release as a medical emergency. These posts connect overdose data to policy choices: what a regulated market buys us, why the reentry window matters, and why fear-based drug policy keeps failing at the one outcome that should matter most — keeping people alive.
All posts All topics Recovery Reentry & Policy
Drug Legalization Series · Part 12
Prison release overdose risk is highest in the first days and weeks after release. This chapter explains which pre-release and post-release programs actually reduce overdose, recidivism, and instability.
Drug Legalization Series · Part 6
Tusi (pink cocaine), xylazine, medetomidine, nitazenes, and THC analogues prove enforcement can’t keep up. Regulation creates testing, labeling, and accountability.
Drug Legalization Series · Part 1
Drug legalization isn’t endorsement. Part 1 explains why punishment fails, why reentry is deadly, and why harm reduction saves lives.